The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for ...

Maternal respiratory syncytial virus (RSV) vaccination and nirsevimab were associated with a reduction in RSV-associated ...

The infant mortality national rate dropped to about 5.5 infant deaths per 1,000 live births in 2024, according to provisional ...

Infant hospitalizations due to respiratory syncytial virus (RSV) infections in the United States dropped as much as 43% last year compared to previous years, following the widespread availability of ...

A new report from the Centers for Disease Control and Prevention shows there was a substantial drop in hospitalizations for respiratory syncytial virus this ... published in the CDC’s online ...

The Centers for Disease Control and Prevention May 8 released an analysis that found declines in hospitalizations for infants infected with respiratory syncytial virus during the 2024-2025 RSV season.

are available in the United States to prevent RSV infection in infants. The largest estimated reductions in hospitalization rates occurred among infants aged up to 2 months, the CDC said.

Maternal RSV vaccination and nirsevimab were associated with a reduction in hospitalization rates among infants aged 0 to 7 months.

In a letter sent Tuesday, Sen. Lisa Blunt Rochester (D-Del.) demanded that health secretary Robert Kennedy clarify whether ...

There was a significant drop in the number of babies hospitalized with RSV this year; a positive news story that can be ...